I now have comprehensive information. Let me compile the complete clinical answer.
Toxoplasmosis in a 22-Year-Old Immunocompetent Male: IgM + IgG Positive
Interpreting the Serology
| Antibody Pattern | Interpretation |
|---|
| IgM (+) + IgG (+) | Acute or recently acquired infection (within the past few weeks to months) |
| IgM (−) + IgG (+) | Past/chronic infection (latent cyst stage) |
| IgM (+) + IgG (−) | Very early acute infection (window period) |
Key caveats (Harrison's 22E):
- IgG titers become detectable 2–3 weeks after infection, peak at 6–8 weeks, then decline slowly to a lifelong baseline.
- IgM can persist for >1 year — a positive IgM does not definitively mean current active disease. It must be interpreted alongside clinical context.
- Antibody avidity testing is the next step when timing is uncertain: high-avidity IgG = infection >3–4 months ago; low-avidity = recent infection.
Pathogen and Life Cycle
Toxoplasma gondii is an obligate intracellular protozoan. The definitive host is the cat (sexual reproduction in gut → oocysts shed in feces). Humans are intermediate hosts infected by:
- Ingestion of undercooked meat containing tissue cysts (bradyzoites)
- Ingestion of oocysts from contaminated soil/water/cat litter
- Transplacental transmission (critical in pregnancy)
- Blood transfusion / organ transplant (less common)
Clinical Presentation in an Immunocompetent Host
In the vast majority of immunocompetent individuals (~80–90%), primary infection is asymptomatic. When symptoms occur:
- Cervical lymphadenopathy — most common finding; rubbery, non-tender nodes, typically posterior cervical
- Mononucleosis-like syndrome: low-grade fever, malaise, fatigue, myalgias, sore throat
- Mild hepatosplenomegaly may occur
- Symptoms are self-limiting, resolving over weeks to months
- Chorioretinitis can occur even in immunocompetent individuals (accounts for ~35% of all chorioretinitis in the US/Europe)
Differential diagnosis to consider: EBV mononucleosis, CMV infection, HIV seroconversion, lymphoma.
What to Do Next for This Patient
- Avidity Testing: Order IgG avidity to determine timing of infection — this is critical for management decisions.
- Eye Exam (Ophthalmology referral): Rule out ocular toxoplasmosis (chorioretinitis), especially if any visual symptoms (blurred vision, floaters, photophobia).
- Assess immune status: Confirm the patient is truly immunocompetent (check for HIV, history of immunosuppressants or malignancy).
- Clinical history: Exposure to cats, recent travel, consumption of raw/undercooked meat, soil exposure.
- PCR (blood/CSF if CNS symptoms) — high specificity but available mainly at specialty labs.
Treatment
Immunocompetent patients with uncomplicated lymphadenopathy do NOT require treatment — the infection is self-limiting.
Treatment is indicated if:
- Severe or persistent symptoms
- Ocular toxoplasmosis (chorioretinitis)
- Immunocompromised host
- Pregnancy (separate regimen applies — spiramycin)
- CNS involvement
Standard treatment regimen (when indicated):
| Drug | Dose | Duration |
|---|
| Pyrimethamine | 200 mg loading, then 50–75 mg/day | 4–6 weeks |
| + Sulfadiazine | 1–1.5 g PO four times daily | 4–6 weeks |
| + Folinic acid (leucovorin) | 10–20 mg/day | Throughout (prevents bone marrow toxicity) |
Alternative if sulfa-allergic: Pyrimethamine + clindamycin, or trimethoprim-sulfamethoxazole (TMP-SMX), or atovaquone.
Pyrimethamine + sulfadiazine act synergistically against T. gondii by inhibiting folate synthesis at two sequential steps. Folinic acid (not folic acid) is added to prevent pyrimethamine-induced megaloblastic anemia. — Harrison's Principles of Internal Medicine, 22E
Key Points Summary
| |
|---|
| Status | Likely acute/recent primary toxoplasmosis |
| Prognosis | Excellent in immunocompetent host |
| Treatment needed? | No, unless symptomatic/ocular/severe |
| Most important next step | IgG avidity + ophthalmology referral |
| Watchout | Reactivation if patient ever becomes immunosuppressed later in life |
The organism persists as bradyzoite-containing tissue cysts for life and can reactivate if the patient becomes immunocompromised (e.g., HIV/AIDS, organ transplant, chemotherapy) — most classically causing toxoplasmic encephalitis (ring-enhancing brain lesions on MRI).
— Harrison's Principles of Internal Medicine, 22E (2025)